Assisted Reproductive Technology Not Tied to Higher BMI in Childhood
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 20, 2023 -- Being born after assisted reproductive technology (ART) is not associated with higher body mass index (BMI) at age 5 to 8 years, according to a study published online Dec. 19 in PLOS Medicine.
Kristina Laugesen, M.D., Ph.D., from Aarhus University in Denmark, and colleagues examined associations between different fertility treatments and BMI in children at age 5 to 8 years. The analysis included 327,301 Danish children born between 2007 and 2012 (13,675 born after ART and 7,728 born after ovulation induction with or without intrauterine insemination [OI/IUI]).
The researchers found that the crude prevalence of obesity was 1.9 percent in children born after ART, 2.0 percent in those born after OI/IUI, and 2.7 percent in those born after no fertility treatment. Children born after ART and OI/IUI had the same prevalence of being overweight (11 percent; prevalence odds ratio [POR], 1.00 [95 percent confidence interval (CI), 0.91 to 1.11]; P = 0.95) or obese (1.9 percent; POR, 1.01 [95 percent CI, 0.79 to 1.29]; P = 0.94) in adjusted analyses. A similar pattern was seen when comparing intracytoplasmic sperm injection with conventional in vitro fertilization (overweight: POR, 0.95 [95 percent CI, 0.83 to 1.07]; P = 0.39; obesity: POR, 1.16 [95 percent CI, 0.84 to 1.61]; P = 0.36). After frozen-thawed (2.7 percent) embryo transfer, obesity was more prevalent than after fresh embryo transfer (1.8 percent; POR, 1.54 [95 percent CI, 1.09 to 2.17]; P = 0.01).
"Our overall null results provide reassuring results for couples with infertility seeking help," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
ASCO: Survivors of Early Breast Cancer Can Successfully Attempt Pregnancy
THURSDAY, May 23, 2024 -- Most survivors of stage 0 to III breast cancer who attempt pregnancy postdiagnosis are able to become pregnant and have a live birth, according to a...
GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults
WEDNESDAY, May 22, 2024 -- For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.